共 14 条
[1]
Neurology[C]. The 5th International Congress of Pathophysiology,2006
[2]
Neurology[C]. The 5th International Congress of Pathophysiology,2006
[3]
Anti parkinsonian therapies and brain mitochondrial complex Ⅰ activit y. Przedborski S,Jackson Lewis V,Fahn S. Movement Disorders . 1995
[4]
Concentration - response relationshi p of levodopa in patients at different stage of Parkinson ’ s disease. Harder S,Baas H. Clinical Pharmacology &Therapeutics . 1998
[5]
Neurology[C]. The 5th International Congress of Pathophysiology,2006
[6]
Degeneration of dopaminergic neurons and free radicals: possible partici pation of levodopa. Ogawa N,Edamatsu R,Mizukawa K,et al. Advances in Neurology . 1993
[7]
L-DOPA cytotoxicit y to PC12 cells in culture is via its autoxidation. Basma AN,Morris EJ,Nicklas WJ,et al. Journal of Neurochemistry . 1995
[8]
Neurology[C]. The 5th International Congress of Pathophysiology,2006
[9]
Toxic effect of L - dopa on mesencephalic cell culture: Protection with antioxidants. Pardo B,Mena Ma,Casare jos MJ,et al. Brain Research . 1995
[10]
Human positronemission tomographic( 18F) Fluorodopa studies correlate with dopamine cell counts and levels. Snow BJ,Tooyawa I,McGeer EG,et al. Annals of Neurology . 1993